Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 832 across all filing types
Latest filing 2026-06-10 Director's Dealing
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare ASA: Mandatory notification of trade - Attachment: 260610 PDMR Attachment Morten Foros Krohnstad.pdf
Director's Dealing Classification · 95% confidence The document is a notification by a person discharging managerial responsibilities (the chair of the board) detailing an insider transaction (exercise of warrants), including prices, volumes, dates, and instrument identification. This fits the definition of Director’s Dealing (insider trades).
2026-06-10 English
Lifecare ASA: Mandatory notification of trade - Attachment: Lifecare ASA- Mandatory notification of trade.pdf
Director's Dealing Classification · 99% confidence The document is a press release titled "Mandatory Notification of Trade" that discloses an insider (the Chair of the Board) exercising warrants and subscribing to shares. It cites the Securities Trading Act and MAR. This is a report of a director’s personal share transaction, fitting the definition of Director’s Dealing (Code: DIRS).
2026-06-10 English
Lifecare ASA: Mandatory notification of trade
Director's Dealing Classification · 93% confidence The document is a mandatory notification of trade by a primary insider (Chair of the Board) detailing a warrant exercise and resulting share holdings. This falls squarely under insider share transactions by executives. Therefore, it is a Director’s Dealing filing.
2026-06-10 English
Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response - Attachment: Lifecare completes first six-month implant evaluation with continued
Regulatory Filings Classification · 43% confidence The document is a corporate press release announcing a product development milestone (six-month implant evaluation) for Lifecare ASA. It does not contain financial results, board changes, capital events, or shareholder voting details. It is not an AGM presentation or investor presentation, nor a formal report or regulatory filing in the sense of financial statements. Therefore, it falls into the catch-all category for miscellaneous regulatory/press announcements.
2026-06-10 English
Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response
Regulatory Filings Classification · 12% confidence The document is a corporate press release announcing a successful six-month veterinary implant evaluation and contains no financial data, no shareholder meeting information, no regulatory form references, no capital or dividend details, and no substantive financial report. It does not fit any specific category (e.g., 10-K, IR, ER, M&A, etc.). Therefore it falls into the fallback category for miscellaneous regulatory or corporate announcements: Regulatory Filings (RNS).
2026-06-10 English
Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue - Attachment: Lifecare ASA- Last day of trading in Warrants Series 2 issued in connection with the Rig
Capital/Financing Update Classification · 80% confidence The document is a press release detailing the last trading day of warrant Series 2 issued in connection with a rights issue and outlining the exercise period, dilution risk, and trading suspension. This concerns a financing activity and capital structure update rather than a regulatory filing, financial report, or shareholder vote. Therefore, it falls under Capital/Financing Update (CAP).
2026-06-05 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.